A208370 Stock Overview
Operates as a medical device company in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
SELVAS Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,080.00 |
| 52 Week High | ₩7,460.00 |
| 52 Week Low | ₩3,425.00 |
| Beta | -0.36 |
| 1 Month Change | -15.62% |
| 3 Month Change | -22.14% |
| 1 Year Change | -39.20% |
| 3 Year Change | 40.21% |
| 5 Year Change | 27.50% |
| Change since IPO | -66.96% |
Recent News & Updates
Returns Are Gaining Momentum At SELVAS Healthcare (KOSDAQ:208370)
Nov 29
SELVAS Healthcare, Inc.'s (KOSDAQ:208370) Popularity With Investors Is Under Threat From Overpricing
Nov 11Estimating The Fair Value Of SELVAS Healthcare, Inc. (KOSDAQ:208370)
Oct 25Recent updates
Returns Are Gaining Momentum At SELVAS Healthcare (KOSDAQ:208370)
Nov 29SELVAS Healthcare, Inc.'s (KOSDAQ:208370) Popularity With Investors Is Under Threat From Overpricing
Nov 11Estimating The Fair Value Of SELVAS Healthcare, Inc. (KOSDAQ:208370)
Oct 25SELVAS Healthcare (KOSDAQ:208370) Is Looking To Continue Growing Its Returns On Capital
Aug 27Subdued Growth No Barrier To SELVAS Healthcare, Inc. (KOSDAQ:208370) With Shares Advancing 32%
Jul 30We Think SELVAS Healthcare (KOSDAQ:208370) Can Manage Its Debt With Ease
Jul 25Investors Shouldn't Be Too Comfortable With SELVAS Healthcare's (KOSDAQ:208370) Earnings
Mar 27Is SELVAS Healthcare (KOSDAQ:208370) Using Too Much Debt?
Mar 11SELVAS Healthcare's (KOSDAQ:208370) Stock Price Has Reduced 62% In The Past Three Years
Jan 26
What Do The Returns At SELVAS Healthcare (KOSDAQ:208370) Mean Going Forward?
Jan 03We Wouldn't Rely On SELVAS Healthcare's (KOSDAQ:208370) Statutory Earnings As A Guide
Dec 08Shareholder Returns
| A208370 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -10.3% | 0.7% | -1.6% |
| 1Y | -39.2% | -2.0% | -9.1% |
Return vs Industry: A208370 underperformed the KR Medical Equipment industry which returned -2% over the past year.
Return vs Market: A208370 underperformed the KR Market which returned -9.1% over the past year.
Price Volatility
| A208370 volatility | |
|---|---|
| A208370 Average Weekly Movement | 9.5% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.6% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A208370's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A208370's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 118 | Chul-Joong Kwon | www.selvashealthcare.com |
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name.
SELVAS Healthcare, Inc. Fundamentals Summary
| A208370 fundamental statistics | |
|---|---|
| Market cap | ₩104.93b |
| Earnings (TTM) | ₩2.14b |
| Revenue (TTM) | ₩29.27b |
49.1x
P/E Ratio3.6x
P/S RatioIs A208370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A208370 income statement (TTM) | |
|---|---|
| Revenue | ₩29.27b |
| Cost of Revenue | ₩14.15b |
| Gross Profit | ₩15.12b |
| Other Expenses | ₩12.99b |
| Earnings | ₩2.14b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 83.06 |
| Gross Margin | 51.66% |
| Net Profit Margin | 7.30% |
| Debt/Equity Ratio | 3.4% |
How did A208370 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 19:30 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SELVAS Healthcare, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Je Yoon Han | KB Securities Co., Ltd. |